Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) EBITDA Margin (2019 - 2023)

Historic EBITDA Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 66257.14%.

  • Benitec Biopharma's EBITDA Margin changed N/A to 66257.14% in Q2 2023 from the same period last year, while for Mar 2024 it was 309628.57%, marking a year-over-year decrease of 2812241600.0%. This contributed to the annual value of 25529.33% for FY2023, which is 8745400.0% down from last year.
  • According to the latest figures from Q2 2023, Benitec Biopharma's EBITDA Margin is 66257.14%.
  • In the past 5 years, Benitec Biopharma's EBITDA Margin registered a high of 6157.14% during Q2 2020, and its lowest value of 393300.0% during Q1 2021.
  • Over the past 5 years, Benitec Biopharma's median EBITDA Margin value was 10725.0% (recorded in 2020), while the average stood at 80603.12%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first crashed by 2000000000bps in 2021, then soared by 2000000000bps in 2022.
  • Over the past 5 years, Benitec Biopharma's EBITDA Margin (Quarter) stood at 2277.92% in 2019, then crashed by -13263bps to 304400.0% in 2020, then skyrocketed by 94bps to 19512.0% in 2021, then crashed by -104bps to 39792.86% in 2022, then crashed by -67bps to 66257.14% in 2023.
  • Its last three reported values are 66257.14% in Q2 2023, 8059.26% for Q1 2023, and 39792.86% during Q4 2022.